Watch For Semglee to Be "Interchangeable" With Lantus
September 2021
Semglee (insulin glargine-yfgn U-100) will be the first "interchangeable" biosimilar.
It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx.
Now Semglee is both biosimilar to, and interchangeable with, Lantus. Biosimilars have to show similar safety, purity, and potency as the original, or "reference," biologic.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote